Van Well Daan 4
4 · SOPHiA GENETICS SA · Filed Apr 8, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CLO Daan Van Well Sells Shares
What Happened
- Daan Van Well, Chief Legal Officer of SOPHiA GENETICS SA (SOPH), sold a total of 5,105 shares in two open-market transactions to satisfy tax withholding on vested restricted stock units. On 2026-04-06 he sold 2,705 shares at a weighted average price of $4.86 for proceeds of $13,136 (footnote F2). On 2026-04-07 he sold 2,400 shares at a weighted average price of $4.87 for proceeds of $11,682 (footnote F3). Total proceeds were approximately $24,818.
Key Details
- Transaction dates and reported prices:
- 2026-04-06: 2,705 shares sold, weighted avg price $4.86 (individual prices ranged $4.685–$4.95) — $13,136 (F2).
- 2026-04-07: 2,400 shares sold, weighted avg price $4.87 (individual prices ranged $4.77–$4.945) — $11,682 (F3).
- Purpose: Sales were to satisfy tax withholding obligations from RSU vestings on April 2 and 3, 2026 (footnote F1).
- Trading plan: Sales were effected pursuant to a pre-established Rule 10b5-1 plan and are described as non-discretionary (F1).
- Shares owned after the transactions: Not disclosed in the summary information provided.
- Filing timeliness: Form 4 was filed on 2026-04-08; based on the transaction dates (4/6 and 4/7) this appears to be a timely report.
Context
- These were routine, tax-withholding sales of vested RSUs under a 10b5-1 plan, not new purchases or directional bets. The insider has offered to provide, on request, a breakdown of how many shares were sold at each specific price within the reported ranges.
Insider Transaction Report
Form 4
Van Well Daan
Chief Legal Officer
Transactions
- Sale
Ordinary Shares
[F1][F2]2026-04-06$4.86/sh−2,705$13,136→ 356,069 total - Sale
Ordinary Shares
[F1][F3]2026-04-07$4.87/sh−2,400$11,682→ 353,669 total
Footnotes (3)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.685 to $4.95, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.77 to $4.945, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Elimara Brunetto as Attorney-in-Fact for Daan van Well|2026-04-08